Los Angeles Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,083
| Closed | -$24.8K | – | 1224 |
|
|
2023
Q2 | $24.8K | Buy |
19,083
+3,412
| +22% | +$4.44K | ﹤0.01% | 1147 |
|
|
2023
Q1 | $27.6K | Sell |
15,671
-2,405
| -13% | -$4.23K | ﹤0.01% | 1149 |
|
|
2022
Q4 | $56.8K | Sell |
18,076
-90,267
| -83% | -$283K | ﹤0.01% | 1176 |
|
|
2022
Q3 | $531K | Buy |
108,343
+61,285
| +130% | +$300K | ﹤0.01% | 908 |
|
|
2022
Q2 | $195K | Hold |
47,058
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q1 | $273K | Hold |
47,058
| – | – | ﹤0.01% | 1275 |
|
|
2021
Q4 | $353K | Sell |
47,058
-13,095
| -22% | -$98.2K | ﹤0.01% | 1173 |
|
|
2021
Q3 | $542K | Hold |
60,153
| – | – | ﹤0.01% | 1012 |
|
|
2021
Q2 | $720K | Sell |
60,153
-3,500
| -5% | -$41.9K | ﹤0.01% | 1004 |
|
|
2021
Q1 | $798K | Sell |
63,653
-103,320
| -62% | -$1.3M | ﹤0.01% | 1007 |
|
|
2020
Q4 | $2.61M | Buy |
166,973
+93,361
| +127% | +$1.46M | 0.01% | 576 |
|
|
2020
Q3 | $696K | Buy |
73,612
+29,120
| +65% | +$275K | ﹤0.01% | 952 |
|
|
2020
Q2 | $399K | Buy |
+44,492
| New | +$399K | ﹤0.01% | 1191 |
|
|
2018
Q4 | – | Sell |
-89,686
| Closed | -$1.52M | – | 1370 |
|
|
2018
Q3 | $1.52M | Hold |
89,686
| – | – | 0.01% | 743 |
|
|
2018
Q2 | $1.27M | Buy |
89,686
+43,000
| +92% | +$611K | 0.01% | 825 |
|
|
2018
Q1 | $887K | Buy |
46,686
+31,840
| +214% | +$605K | 0.01% | 865 |
|
|
2017
Q4 | $243K | Buy |
+14,846
| New | +$243K | ﹤0.01% | 1219 |
|
|
2015
Q2 | – | Sell |
-22,560
| Closed | -$354K | – | 1246 |
|
|
2015
Q1 | $354K | Buy |
+22,560
| New | +$354K | ﹤0.01% | 1014 |
|
|
2014
Q3 | – | Sell |
-14,610
| Closed | -$223K | – | 1153 |
|
|
2014
Q2 | $223K | Buy |
+14,610
| New | +$223K | ﹤0.01% | 1115 |
|